Pharmaceutical companies’ concerns over ‘Financial Gain & Expenditure Report’ even before it starts
While being active in preparing for the ‘Financial Gain & Expenditure Report’ which will be implemented from 1 January 2018, pharmaceutical companies have encountered a new concern.
When the report became obligated, pharmaceutical companies were worried about the report itself, but they now have...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.